Distinct modulation of calcium-activated chloride channel TMEM16A by drug-binding sites
Proceedings of the National Academy of Sciences · 2024
DOI: 10.1073/pnas.2314011121 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2024. Verfasst von Jae Won Roh und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Graduate School of Medical Science, Brain Korea 21 Project, Yonsei University College of Medicine, Seoul 03722, Republic …. Hauptthemen laut MEDLINE: Anoctamin-1, Molecular Dynamics Simulation, Molecular Docking Simulation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Research Foundation of Korea (NRF), Korea Health Industry Development Institute (KHIDI), New York Stem Cell Foundation (NYSCF).
Abstract (Originalsprache)
TMEM16A is a calcium-activated chloride channel with significant role in epithelial fluid secretion, sensory transduction, and smooth muscle contraction. Several TMEM16A inhibitors have been identified; however, their binding sites and inhibitory mechanisms remain unclear. Using magnolol and honokiol, the two regioisomeric inhibitors, as chemical probes, we have identified a drug-binding site distinct from the pore region, in TMEM16A, which is described here. With electrophysiology, unbiased molecular docking and clustering, molecular dynamics simulations, and experimental validation with mutant cycle analysis, we show that magnolol and honokiol utilize different drug-binding sites, pore and nonpore pockets. The pore blocker utilizes amino acids crucial for chloride passage, whereas the nonpore blocker allosterically modulates the pore residues to hinder ion permeation. Among 17 inhibitors tested, 11 were pore blockers and 6 were nonpore blockers, indicating the importance of this nonpore pocket. Our study provides insights into drug-binding mechanism in TMEM16A together with a rationale for future drug development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, Graduate School of Medical Science, Brain Korea 21 Project, Yonsei University College of Medicine, Seoul 03722, Republic of Korea.
- Channelopathy Research Center, Dongguk University College of Medicine, Goyang 10326, Republic of Korea.
- Department of Physiology, Dongguk University College of Medicine, Gyeongju 38066, Republic of Korea.
- Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114.
- Department of Internal Medicine, Dongguk University Graduate School of Medicine, Goyang 10326, Republic of Korea.
- Department of Biochemistry, Kangwon National University, Chuncheon 24341, Republic of Korea.
ORCID-Profile: Jae Won Roh, Heon Yung Gee, Brian Wainger, Woo Kyung Kim, Wook Lee, Joo Hyun Nam
Förderung
- National Research Foundation of Korea (NRF)
- Korea Health Industry Development Institute (KHIDI)
- New York Stem Cell Foundation (NYSCF)
- Kangwon National University (KNU)
- Dongguk University (DU)
Zitieren
APA
Roh, J. W., Gee, H. Y., Wainger, B., Kim, W. K., Lee, W., & Nam, J. H. (2024). Distinct modulation of calcium-activated chloride channel TMEM16A by drug-binding sites. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2314011121
Vancouver
Roh JW, Gee HY, Wainger B, Kim WK, Lee W, Nam JH. Distinct modulation of calcium-activated chloride channel TMEM16A by drug-binding sites. Proceedings of the National Academy of Sciences. 2024. doi:10.1073/pnas.2314011121
BibTeX
@article{Roh2024,
author = {Roh, Jae Won and Gee, Heon Yung and Wainger, Brian and Kim, Woo Kyung and Lee, Wook and Nam, Joo Hyun},
title = {Distinct modulation of calcium-activated chloride channel TMEM16A by drug-binding sites},
journal = {Proceedings of the National Academy of Sciences},
year = {2024},
doi = {10.1073/pnas.2314011121}
}
EUVIMED